Author Correction: The interaction of β-arrestin1 with talin1 driven by endothelin A receptor as a feature of α5β1 integrin activation in high-grade serous ovarian cancer

被引:0
|
作者
Ilenia Masi [1 ]
Flavia Ottavi [1 ]
Danila Del Rio [1 ]
Valentina Caprara [2 ]
Cristina Vastarelli [1 ]
Sara Maria Giannitelli [3 ]
Giulia Fianco [1 ]
Pamela Mozetic [4 ]
Marianna Buttarelli [5 ]
Gabriella Ferrandina [6 ]
Giovanni Scambia [7 ]
Daniela Gallo [6 ]
Alberto Rainer [7 ]
Anna Bagnato [6 ]
Francesca Spadaro [7 ]
Laura Rosanò [6 ]
机构
[1] Institute of Molecular Biology and Pathology,Unit of Preclinical Models and New Therapeutic Agents
[2] CNR,Department of Engineering
[3] IRCCS—Regina Elena National Cancer Institute,Institute of Nanotechnology (NANOTEC)
[4] Università Campus Bio-Medico di Roma,San Raffaele Hospital, Division of Neuroscience
[5] National Research Council (CNR),undefined
[6] c/o Campus Ecotekne,undefined
[7] Institute of Experimental Neurology,undefined
[8] San Raffaele Scientific Institute,undefined
[9] Dipartimento Universitario Scienze della Vita e Sanità Pubblica-Sezione di Ginecologia ed Ostetricia—Università Cattolica del Sacro Cuore,undefined
[10] Dipartimento Scienze della Salute della Donna,undefined
[11] del Bambino e di Sanità Pubblica,undefined
[12] Fondazione Policlinico Universitario A. Gemelli,undefined
[13] IRCCS,undefined
[14] Largo A. Gemelli 8,undefined
[15] Confocal Microscopy Unit,undefined
[16] Core Facilities,undefined
[17] Istituto Superiore di Sanità,undefined
关键词
D O I
10.1038/s41419-024-07139-x
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Development of a Bioluminescent BRCA1-Deficient Xenograft Model of Disseminated, High-Grade Serous Ovarian Cancer
    Shen, Yen Ting
    Wang, Lucy
    Evans, James C.
    Allen, Christine
    Piquette-Miller, Micheline
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (10)
  • [42] Sphingosine-kinase-1 expression is associated with improved overall survival in high-grade serous ovarian cancer
    L. C. Hanker
    A. El-Balat
    Z. Drosos
    S. Kommoss
    T. Karn
    U. Holtrich
    G. Gitas
    M. Graeser-Mayer
    M. Anglesio
    D. Huntsman
    A. Rody
    H. Gevensleben
    F. Hoellen
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 1421 - 1430
  • [43] Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer
    Kyung Jin Eoh
    Hye Min Kim
    Jung-Yun Lee
    Sunghoon Kim
    Sang Wun Kim
    Young Tae Kim
    Eun Ji Nam
    BMC Cancer, 20
  • [44] Sphingosine-kinase-1 expression is associated with improved overall survival in high-grade serous ovarian cancer
    Hanker, L. C.
    El-Balat, A.
    Drosos, Z.
    Kommoss, S.
    Karn, T.
    Holtrich, U.
    Gitas, G.
    Graeser-Mayer, M.
    Anglesio, M.
    Huntsman, D.
    Rody, A.
    Gevensleben, H.
    Hoellen, F.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (05) : 1421 - 1430
  • [45] RUNX1 knockdown induced apoptosis and impaired EMT in high-grade serous ovarian cancer cells
    Yuanzhi Chen
    Zhicheng He
    Shuting Yang
    Cheng Chen
    Wenyong Xiong
    YingYing He
    Shubai Liu
    Journal of Translational Medicine, 21
  • [46] Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer
    Christie, Elizabeth L.
    Pattnaik, Swetansu
    Beach, Jessica
    Copeland, Anthony
    Rashoo, Nineveh
    Fereday, Sian
    Hendley, Joy
    Alsop, Kathryn
    Brady, Samuel L.
    Lamb, Greg
    Pandey, Ahwan
    deFazio, Anna
    Thorne, Heather
    Bild, Andrea
    Bowtell, David D. L.
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [47] RUNX1 knockdown induced apoptosis and impaired EMT in high-grade serous ovarian cancer cells
    Chen, Yuanzhi
    He, Zhicheng
    Yang, Shuting
    Chen, Cheng
    Xiong, Wenyong
    He, Yingying
    Liu, Shubai
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [48] NB compounds are potent and efficacious FOXM1 inhibitors in high-grade serous ovarian cancer cells
    Liu, Cassie
    Vorderbruggen, Makenzie
    Munoz-Trujillo, Catalina
    Kim, Sung Hoon
    Katzenellenbogen, John A.
    Katzenellenbogen, Benita S.
    Karpf, Adam R.
    JOURNAL OF OVARIAN RESEARCH, 2024, 17 (01)
  • [49] Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer
    Eoh, Kyung Jin
    Kim, Hye Min
    Lee, Jung-Yun
    Kim, Sunghoon
    Kim, Sang Wun
    Kim, Young Tae
    Nam, Eun Ji
    BMC CANCER, 2020, 20 (01)
  • [50] SLCO4A1 expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer
    Koller, Stephanie
    Kendler, Jonatan
    Karacs, Jasmine
    Wolf, Andrea
    Kreuzinger, Caroline
    Von der Decken, Isabel
    Mungenast, Felicitas
    Mechtcheriakova, Diana
    Schreiner, Wolfgang
    Gleiss, Andreas
    Jaeger, Walter
    Castillo-Tong, Dan Cacsire
    Thalhammer, Theresia
    FRONTIERS IN PHARMACOLOGY, 2022, 13